Status:
COMPLETED
Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension
Lead Sponsor:
Daiichi Sankyo Co., Ltd.
Conditions:
Hypertension
Eligibility:
All Genders
20-74 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to test the efficacy and safety of the combination of Calcium Channel Blockers (CCBs)(of the dihydropyridine class) or Diuretics (of the thiazide class) and olmesartan medo...
Eligibility Criteria
Inclusion
- Mean seated blood pressure greater than or equal to 140/90 mmHg under circumstances in pre-treatment with olmesartan medoxomil
- Mean 24-hour blood pressure evaluated by ambulatory blood pressure monitoring greater than or equal to 135/80 mmHg under circumstances in pre-treatment with olmesartan medoxomil
Exclusion
- Patients with secondary hypertension
- Any serious disorder which may limit the ability to evaluate the efficacy or safety of the test drugs
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2005
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT00858702
Start Date
February 1 2005
End Date
November 1 2005
Last Update
October 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tokyo, Japan